Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,229.20
(
1.84%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
95.96
(
-1.06%
)
Bitcoin
75,775.45
(
-0.09%
)
News Focus
News Focus
Post# of 5084
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Wildbilly

Send PM Follow Ignore
Followers 229
Posts 34993
Boards Moderated 1
Alias Born 11/19/2003

Wildbilly

Re: None

Wednesday, 04/10/2013 8:29:05 AM

Wednesday, April 10, 2013 8:29:05 AM

Post# of 5084
BioCryst Pharmaceuticals (NASDAQ:BCRX): MLV Capital upgraded its rating on this company from Hold to Buy and changed its price target to $3.00.

Check your six.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent BCRX News
More BCRX News